Ibrance 75 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26F23T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,123
Award facts
- Contract value 100% obligated
- $17,122.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg tablets in a quantity of seven units, with a ceiling value of $17,122.82. This contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major prime vendor under the DLA Medical Supply Chain, the company maintains extensive capabilities to provide brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Ibrance delivery represents typical procurement activity under the company's comprehensive pharmaceutical support vehicle, which enables flexible fulfillment of military and federal healthcare requirements globally. DLA Troop Support is planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key strategic vendors supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F23T3?
SPE2DR26F23T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F23T3 worth?
The government has obligated $17,123 on SPE2DR26F23T3.
Is contract SPE2DR26F23T3 an order under another contract?
Yes. SPE2DR26F23T3 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23T3 competed?
The extent of competition for SPE2DR26F23T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award